Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1907 4
1908 3
1909 1
1910 3
1911 1
1912 3
1913 1
1920 1
1924 1
1932 2
1955 1
1957 2
1958 5
1959 2
1960 1
1961 4
1962 2
1963 2
1964 3
1965 2
1966 3
1967 3
1968 4
1969 2
1970 3
1971 2
1972 3
1973 2
1975 1
1976 2
1977 3
1978 1
1979 1
1980 2
1981 1
1982 1
1983 4
1984 5
1985 1
1986 3
1988 3
1989 4
1990 2
1991 3
1992 4
1993 5
1994 3
1995 1
1996 3
1997 3
1998 4
1999 1
2000 3
2001 3
2002 3
2003 2
2004 9
2005 3
2006 6
2007 4
2008 5
2009 5
2010 2
2011 6
2012 6
2013 4
2014 12
2015 10
2016 1
2017 2
2018 5
2019 4
2020 7
2021 8
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
PD Med Collaborative Group; Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. PD Med Collaborative Group, et al. Lancet. 2014 Sep 27;384(9949):1196-205. doi: 10.1016/S0140-6736(14)60683-8. Epub 2014 Jun 11. Lancet. 2014. PMID: 24928805 Clinical Trial.
Respiratory dysfunction in Parkinson's disease.
Torsney KM, Forsyth D. Torsney KM, et al. Among authors: forsyth d. J R Coll Physicians Edinb. 2017 Mar;47(1):35-39. doi: 10.4997/JRCPE.2017.108. J R Coll Physicians Edinb. 2017. PMID: 28569280 Review.
Intrinsic Image Decomposition Using Paradigms.
Forsyth D, Rock JJ. Forsyth D, et al. IEEE Trans Pattern Anal Mach Intell. 2022 Nov;44(11):7624-7637. doi: 10.1109/TPAMI.2021.3119551. Epub 2022 Oct 4. IEEE Trans Pattern Anal Mach Intell. 2022. PMID: 34648429
Tolterodine-induced hyponatraemia.
Juss JK, Radhamma AK, Forsyth DR. Juss JK, et al. Among authors: forsyth dr. Age Ageing. 2005 Sep;34(5):524-5. doi: 10.1093/ageing/afi131. Age Ageing. 2005. PMID: 16107463
Animal welfare science aids conservation.
Hampton JO, Baker SE, Beausoleil NJ, Cattet M, Forsyth DM, McMahon CR, Proulx G, Warburton B. Hampton JO, et al. Among authors: forsyth dm. Science. 2020 Oct 9;370(6513):180-181. doi: 10.1126/science.abe2171. Science. 2020. PMID: 33033212 No abstract available.
Improving pain detection in older patients.
Juss JK, Forsyth DR. Juss JK, et al. Among authors: forsyth dr. Practitioner. 2008 Apr;252(1705):40, 43, 45-7. Practitioner. 2008. PMID: 18510258 Review. No abstract available.
240 results